Targeted disruption of EPOR causes a marked reduction of primitive erythroblasts by E10.5–E11.5 and a profound anemia by E12.5 (Wu et al., 1995; Kieran et al., 1996; Lin et al., 1996; Malik et al., 2013). The gene discussed is EPOR; the disease is anemia.